A Single-Arm, Phase 2 Trial of Combined Bevacizumab and Nivolumab in Relapsed Ovarian Cancer

This phase 2 clinical trial examines the use of nivolumab combined with bevacizumab in treatment of women with relapsed platinum-sensitive or platinum-resistant ovarian cancer.

Read the full article here

Related Articles